Development and evaluation of multiplexed immunoassay for detection of antibodies to HPV vaccine types

Journal of Immunological Methods

Volumn 417, Issue , 2015, Pages 107-114

  Panicker, G ^a   Rajbhandari, I ^a   Gurbaxani, B M ^a   Querec, T D ^a   Unger, E R ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

ELISA; HPV antibodies; Meso Scale Discovery; Multiplex; Serology

Indexed keywords

HUMAN PAPILLOMAVIRUS TYPE 11 ANTIBODY; HUMAN PAPILLOMAVIRUS TYPE 16 ANTIBODY; HUMAN PAPILLOMAVIRUS TYPE 18 ANTIBODY; HUMAN PAPILLOMAVIRUS TYPE 6 ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY; WART VIRUS VACCINE;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CHEMILUMINESCENCE IMMUNOASSAY; CHEMOLUMINESCENCE; COMPETITIVE LUMINEX IMMUNOASSAY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; IMMUNOASSAY; LIMIT OF DETECTION; PH; PRIORITY JOURNAL; VIRUS LIKE AGENT; BLOOD; CHILD; ELECTROCHEMICAL ANALYSIS; EVALUATION STUDY; FEMALE; IMMUNOLOGY; MALE; PROCEDURES;

HUMAN PAPILLOMAVIRUS;

ANTIBODIES, VIRAL; CHILD; ELECTROCHEMICAL TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN PAPILLOMAVIRUS 11; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMAN PAPILLOMAVIRUS 6; HUMANS; MALE; PAPILLOMAVIRUS VACCINES;

EID: 84922982458     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2014.12.013     Document Type: Article

References (21)

1. Akaike H. A new look at the statistical model identification. IEEE Trans. Autom. Control 1974, 19:716.
2. Chang B.S., Mahoney R.R. Enzyme thermostabilization by bovine serum albumin and other proteins: evidence for hydrophobic interactions. Biotechnol. Appl. Biochem. 1995, 22(Pt 2):203.
3. Dias D., Van D.J., Schlottmann S., Kelly S., Puchalski D., Ruiz W., Boerckel P., Kessler J., Antonello J.M., Green T., Brown M., Smith J., Chirmule N., Barr E., Jansen K.U., Esser M.T. Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18. Clin. Diagn. Lab. Immunol. 2005, 12:959.
4. Ferguson M., Wilkinson D.E., Zhou T. WHO meeting on the standardization of HPV assays and the role of the WHO HPV Laboratory Network in supporting vaccine introduction held on 24-25 January 2008, Geneva, Switzerland. Vaccine 2009, 27:337.
5. Finn T.E., Nunez A.C., Sunde M., Easterbrook-Smith S.B. Serum albumin prevents protein aggregation and amyloid formation and retains chaperone-like activity in the presence of physiological ligands. J. Biol. Chem. 2012, 287:21530.
6. Grabowska K., Wang X., Jacobsson A., Dillner J. Evaluation of cost-precision ratios of different strategies for ELISA measurement of serum antibody levels. J. Immunol. Methods 2002, 271:1.
7. Johnson N.L. Systems of frequency curves generated by methods of translation. Biometrika 1949, 36:149.
8. Lin S.W., Ghosh A., Porras C., Markt S.C., Rodriguez A.C., Schiffman M., Wacholder S., Kemp T.J., Pinto L.A., Gonzalez P., Wentzensen N., Esser M.T., Matys K., Meuree A., Quint W., van Doorn L.J., Herrero R., Hildesheim A., Safaeian M. HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays. PLoS ONE 2013, 8:e53067.
9. Marchese R.D., Puchalski D., Miller P., Antonello J., Hammond O., Green T., Rubinstein L.J., Caulfield M.J., Sikkema D. Optimization and validation of a multiplex, electrochemiluminescence-based detection assay for the quantitation of immunoglobulin G serotype-specific antipneumococcal antibodies in human serum. Clin. Vaccine Immunol. 2009, 16:387.
10. Opalka D., Lachman C.E., MacMullen S.A., Jansen K.U., Smith J.F., Chirmule N., Esser M.T. Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay. Clin. Diagn. Lab. Immunol. 2003, 10:108.
11. Pastrana D.V., Buck C.B., Pang Y.Y., Thompson C.D., Castle P.E., FitzGerald P.C., Kruger K.S., Lowy D.R., Schiller J.T. Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18. Virology 2004, 321:205.
12. R Core Team R: A Language and Environment for Statistical Computing 2014, R Foundation for Statistical Computing, Vienna, Austria, (http://www.R-project.org/).
13. Romanowski B., de Borba P.C., Naud P.S., Roteli-Martins C.M., De Carvalho N.S., Teixeira J.C., Aoki F., Ramjattan B., Shier R.M., Somani R., Barbier S., Blatter M.M., Chambers C., Ferris D., Gall S.A., Guerra F.A., Harper D.M., Hedrick J.A., Henry D.C., Korn A.P., Kroll R., Moscicki A.B., Rosenfeld W.D., Sullivan B.J., Thoming C.S., Tyring S.K., Wheeler C.M., Dubin G., Schuind A., Zahaf T., Greenacre M., Sgriobhadair A. Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4years. Lancet 2009, 374:1975.
14. Safaeian M., Ghosh A., Porras C., Lin S.W., Rodriguez A.C., Schiffman M., Wacholder S., Kemp T., Gonzalez P., Wentzensen N., Esser M., Meuree A., Matys K., Quint W., van Doorn L.J., Sherman M.E., Herrero R., Pinto L.A., Hildesheim A. Direct comparison of HPV16 serological assays used to define HPV-naive women in HPV vaccine trials. Cancer Epidemiol. Biomarkers Prev. 2012, 21:1547.
15. Scherpenisse M., Schepp R.M., Mollers M., Mooij S.H., Meijer C.J., Berbers G.A., van der Klis F.R. Comparison of different assays to assess human papillomavirus (HPV) type 16- and 18-specific antibodies after HPV infection and vaccination. Clin. Vaccine Immunol. 2013, 20:1329.
16. Schiller J.T., Lowy D.R. Immunogenicity testing in human papillomavirus virus-like-particle vaccine trials. J. Infect. Dis. 2009, 200:166.
17. Schiller J.T., Castellsague X., Garland S.M. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine 2012, 30(Suppl. 5):F123.
18. Schwarz G. Estimating the dimension of a model. Ann. Stat. 1978, 6:461.
19. Wentzensen N., Rodriguez A.C., Viscidi R., Herrero R., Hildesheim A., Ghosh A., Morales J., Wacholder S., Guillen D., Alfaro M., Safaeian M., Burk R.D., Schiffman M. A competitive serological assay shows naturally acquired immunity to human papillomavirus infections in the Guanacaste Natural History Study. J. Infect. Dis. 2011, 204:94.
20. WHO HPV Labnet Human Papillomavirus Laboratory Manual (WHO/IVB/10.12) http://whqlibdoc.who.int/hq/2010/WHO_IVB_10.12_eng.pdf?ua=1.
21. Wickham H. ggplot2: Elegant Graphics for Data Analysis 2009, Springer, New York.